Claudia Herrera‐deGuise

597 total citations · 1 hit paper
24 papers, 312 citations indexed

About

Claudia Herrera‐deGuise is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Claudia Herrera‐deGuise has authored 24 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 12 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Claudia Herrera‐deGuise's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (7 papers) and Gut microbiota and health (4 papers). Claudia Herrera‐deGuise is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (7 papers) and Gut microbiota and health (4 papers). Claudia Herrera‐deGuise collaborates with scholars based in Spain, France and Belgium. Claudia Herrera‐deGuise's co-authors include Natalia Borruel, Virginia Robles, Francesc Casellas, Francisco Guarner, Banumathi Ramakrishna, Henry Cohen, Tarkan Karakan, L Mayorga, Mary Ellen Sanders and Dan Merenstein and has published in prestigious journals such as Nutrients, Cells and Inflammatory Bowel Diseases.

In The Last Decade

Claudia Herrera‐deGuise

19 papers receiving 306 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics

2024 58 citations Francisco Guarner, Mary Ellen Sanders et al. Journal of Clinical Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Herrera‐deGuise Spain	9	152	93	80	46	43	24	312
Marc Girardin Switzerland	11	119 0.8×	83 0.9×	56 0.7×	72 1.6×	14 0.3×	20	293
Juan S. Lasa Argentina	8	222 1.5×	195 2.1×	67 0.8×	144 3.1×	25 0.6×	36	438
Rachel Tayler United Kingdom	7	159 1.0×	89 1.0×	60 0.8×	70 1.5×	40 0.9×	20	283
Ofer Ben‐Bassat Israel	10	221 1.5×	170 1.8×	61 0.8×	86 1.9×	8 0.2×	22	312
Naveen Sharma United Kingdom	11	111 0.7×	69 0.7×	147 1.8×	41 0.9×	138 3.2×	26	423
Davide Massimi Italy	11	125 0.8×	119 1.3×	57 0.7×	77 1.7×	8 0.2×	43	346
Antônio Penna Italy	11	93 0.6×	83 0.9×	56 0.7×	79 1.7×	5 0.1×	22	269
Philip H. Sossenheimer United States	10	191 1.3×	150 1.6×	31 0.4×	93 2.0×	15 0.3×	21	314
Derrick Tee Australia	8	88 0.6×	96 1.0×	81 1.0×	52 1.1×	7 0.2×	18	262
Oksana Boyarchuk Ukraine	11	63 0.4×	61 0.7×	95 1.2×	49 1.1×	44 1.0×	103	362

Countries citing papers authored by Claudia Herrera‐deGuise

Since Specialization

Citations

This map shows the geographic impact of Claudia Herrera‐deGuise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Herrera‐deGuise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Herrera‐deGuise more than expected).

Fields of papers citing papers by Claudia Herrera‐deGuise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Herrera‐deGuise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Herrera‐deGuise. The network helps show where Claudia Herrera‐deGuise may publish in the future.

Co-authorship network of co-authors of Claudia Herrera‐deGuise

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Herrera‐deGuise. A scholar is included among the top collaborators of Claudia Herrera‐deGuise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Herrera‐deGuise. Claudia Herrera‐deGuise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mayorga, L, et al.. (2025). Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology. Biomarker Research. 13(1). 85–85. 4 indexed citations

2.

Rodríguez–Lago, Iago, Fiorella Cañete, Claudia Herrera‐deGuise, et al.. (2024). Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología. 47(7). 727–733.

3.

Rodríguez–Lago, Iago, Fiorella Cañete, Claudia Herrera‐deGuise, et al.. (2024). Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología (English Edition). 47(7). 727–733.

4.

Guarner, Francisco, Mary Ellen Sanders, Hania Szajewska, et al.. (2024). World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics. Journal of Clinical Gastroenterology. 58(6). 533–553. 58 indexed citations breakdown →

5.

Robles, Virginia, et al.. (2023). : SEVERE AND REFRACTORY GASTROINTESTINAL TOXICITY DUE TO IMMUNE CHECKPOINT INHIBITORS: CLINICAL EXPERIENCE IN A TERTIARY REFERRAL HOSPITAL. Revista Española de Enfermedades Digestivas. 115(10). 567–573. 5 indexed citations

6.

Herrera‐deGuise, Claudia, Encarna Varela, Guillaume Sarrabayrouse, et al.. (2023). Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota. Inflammatory Bowel Diseases. 29(9). 1362–1369. 20 indexed citations

7.

Herrera‐deGuise, Claudia, et al.. (2023). JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases. Frontiers in Medicine. 10. 1089099–1089099. 49 indexed citations

8.

Herrera‐deGuise, Claudia, Juliana Esperalba, L Mayorga, et al.. (2023). P202 Accuracy of blood-PCR for diagnosing CMV Colitis in patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(Supplement_1). i354–i356.

9.

Mayorga, L, Claudia Herrera‐deGuise, Juliana Esperalba, et al.. (2022). P588 T cell response to SARS-CoV-2 mRNA vaccines by an interferon-gamma release immunoassay in patients with Inflammatory Bowel disease receiving anti-TNF and thiopurine treatment. Journal of Crohn s and Colitis. 16(Supplement_1). i525–i525. 2 indexed citations

10.

Herrera‐deGuise, Claudia, et al.. (2022). Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak. Revista Española de Enfermedades Digestivas. 115(6). 315–319. 3 indexed citations

11.

Bastida, Guillermo, Claudia Herrera‐deGuise, Alicia Algaba, et al.. (2021). Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment. Nutrients. 13(6). 1770–1770. 8 indexed citations

12.

Borruel, Natalia, Virginia Robles, Claudia Herrera‐deGuise, et al.. (2021). Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease. Gastroenterología y Hepatología. 44(7). 481–488. 8 indexed citations

13.

Borruel, Natalia, et al.. (2021). Effectiveness of a Telephone-Based Motivational Intervention for Smoking Cessation in Patients With Crohn Disease. Gastroenterology Nursing. 44(6). 418–425. 4 indexed citations

14.

Sarrabayrouse, Guillaume, Stefania Landolfi, Marta Pozuelo, et al.. (2020). Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation. EBioMedicine. 51. 102611–102611. 23 indexed citations

15.

Robles, Virginia, et al.. (2020). Normalization of long-term quality of life in Crohn�s diseasepatients receiving ustekinumab. Revista Española de Enfermedades Digestivas. 113(5). 313–317. 7 indexed citations

16.

Alcover, M. Magdalena, Natalia Borruel, Elena Sulleiro, et al.. (2020). Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy. Heliyon. 6(5). e03940–e03940. 7 indexed citations

17.

Rodríguez–Lago, Iago, Laura Sempere, Ana Gutiérrez, et al.. (2019). Granulocyte–monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis. Scandinavian Journal of Gastroenterology. 54(4). 459–464. 18 indexed citations

18.

Borruel, Natalia, Claudia Herrera‐deGuise, Encarna Varela, et al.. (2018). P860 Combination of prebiotic FOS and adalimumab for prevention of dysbiosis in active Crohn’s disease: A pilot study. Journal of Crohn s and Colitis. 12(supplement_1). S551–S552. 1 indexed citations

19.

Herrera‐deGuise, Claudia, et al.. (2016). Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22(6). 1450–1455. 33 indexed citations

20.

Casellas, Francesc, et al.. (2016). Patient preferences for inflammatory bowel disease treatment objectives. Digestive and Liver Disease. 49(2). 152–156. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact